The 15 Best-Funded Healthtech Companies
Published 27 October 2026 · 15 companies · Template copy (AI unavailable)
This analysis covers 15 Healthtech companies at the seed stage, which have collectively raised $85.2m in funding. The dataset spans 10 distinct regions.
CardioSense leads the ranking with $15.4m, whilst the average raise across the dataset is $5.7m and the median is $4.2m. The top ten companies account for 89.8% of total funding.
Total Funding (USD)
$85.2m
Average
$5.7m
Median
$4.2m
Top-10 share
89.8%
The Biggest Raises
The top ten companies in this dataset have collectively claimed 89.8% of all funding raised. CardioSense sits at the top with $15.4m, a gap of $3.3m ahead of the second-placed company. The average raise of $5.7m suggests a healthy spread of investor interest across the cohort.
Where They're Based
London is the dominant hub, accounting for 5 of the 15 companies and $39.4m in funding. The dataset spans 10 regions in total, highlighting the geographic spread of Healthtech activity.
What They're Building
The most common sector tags across the dataset are: Oncology, AI diagnostics, Wearables, Mental health, AI. These themes reflect the core technological and commercial focus of the current Healthtech cohort.
Trends to Watch
With 15 companies at the seed stage raising a combined $85.2m, the Healthtech sector is demonstrating strong investor appetite. The concentration of activity in London underscores the importance of established tech ecosystems, whilst the median raise of $4.2m suggests most founders are securing meaningful capital without relying on outlier rounds.
Key Insights
- ▸15 Healthtech companies have collectively raised $85.2m.
- ▸The top 10 companies account for 89.8% of all funding raised.
- ▸London is the leading hub with 5 companies.
- ▸Average raise: $5.7m · Median raise: $4.2m.
- ▸CardioSense leads the ranking with $15.4m.
- ▸Most common sector: "Oncology" (3 companies).
Funding (USD) by Region
Top Sector Tags
Full Rankings (15 of 15)
| Name | Funding (USD) | Location | Sector | Description |
|---|---|---|---|---|
| MediScan AI | $4200000 | London | Medical imaging; AI diagnostics; Radiology | MediScan AI develops deep-learning software for automated analysis of radiology images to help radiologists prioritise urgent cases. |
| CareLoop | $3800000 | Manchester | Remote patient monitoring; Chronic disease management; Wearables | CareLoop builds wearable-integrated software for continuous patient monitoring and early deterioration alerts. |
| GenomixPro | $12100000 | Cambridge | Genomics; Drug discovery; Bioinformatics; Oncology | GenomixPro develops a cloud platform for genomic data analysis and drug target identification aimed at accelerating rare-disease research. |
| TherapyOS | $1900000 | Bristol | Mental health; Digital therapeutics; Cognitive behavioural therapy | TherapyOS offers a CBT-based mobile app for anxiety and depression management that is clinically validated and NICE-compliant. |
| NanoMed | $8700000 | Oxford | Drug delivery; Nanotechnology; Oncology; Targeted therapy | NanoMed develops targeted nanoparticle drug delivery systems for solid tumour treatment to reduce off-target toxicity. |
| HealthChain | $2500000 | London | Healthcare data; Blockchain; Patient records; Interoperability | HealthChain builds a blockchain-based platform for secure consent-driven patient data sharing between NHS trusts. |
| SurgAssist | $6300000 | Edinburgh | Surgical robotics; AI; Orthopaedics; Computer vision | SurgAssist develops AI-guided robotic assistance tools for orthopaedic surgeons to improve implant placement accuracy. |
| PharmaTrack | $1200000 | Leeds | Pharmaceutical supply chain; Drug traceability; Compliance | PharmaTrack builds a serialisation and traceability platform for pharmaceutical logistics to meet EU Falsified Medicines Directive requirements. |
| BioMark | $9500000 | London | Biomarkers; Diagnostics; Early detection; Oncology | BioMark develops blood-based biomarker tests for early cancer and neurological disease detection from a standard blood draw. |
| VisionRx | $3100000 | Glasgow | Ophthalmology; AI diagnostics; Telehealth; Screening | VisionRx builds AI-powered remote eye examination tools to bring specialist-level screening to underserved rural communities. |
| WellnessAI | $2200000 | Birmingham | Preventive health; Personalisation; Nutrition; Behaviour change | WellnessAI develops a personalised health coaching app using AI and biomarker data to nudge healthier lifestyle choices. |
| CardioSense | $15400000 | London | Cardiology; Wearables; Remote monitoring; ECG; Arrhythmia | CardioSense develops wearable ECG patches and a cloud platform for continuous cardiac monitoring with automated arrhythmia alerts. |
| MindBridge | $900000 | Cardiff | Mental health; Peer support; Community health; Social prescribing | MindBridge builds a moderated social platform connecting people experiencing mental health challenges with peer mentors. |
| ClinTrialX | $5600000 | Oxford | Clinical trials; Patient recruitment; Research operations; AI | ClinTrialX develops AI software to match patients to open clinical trials and streamline trial site management workflows. |
| HealthNLP | $7800000 | London | NLP; Clinical documentation; EHR integration; Speech recognition | HealthNLP builds natural language processing tools for automating clinical note-taking and diagnostic coding in real time. |
Frequently Asked Questions
How much have Healthtech companies raised in total?
The 15 companies in this dataset have collectively raised $85,200,000.
Which Healthtech company has raised the most funding?
CardioSense leads the ranking with $15.4m in total funding raised.
What is the average raise for a seed-stage Healthtech company?
The average raise across the 15 companies is $5.7m, with a median of $4.2m.